- Generic Name: Brentuximab Vedotin
- Strength: 50 mg
- Packing: Single Vial
Brentuximab Vedotin
Medical uses
Warning & Precautions
Documentation & Availability
Sourcing & Delivery
FAQ
Medical uses
Brentuximab Vedotin is a CD30-directed antibody-drug conjugate drug. The uses of adcetris injection are:
- Hodgkin lymphoma following the failure of autologous stem cell transplant (ASCT) or following the failure of a minimum of two prior multi-agent chemo regimens in patients who are not ASCT candidates.
- Systemic anaplastic large cell lymphoma following the failure of at least one prior multi-agent chemotherapy regimen.
- Previously untreated stage III or IV classical Hodgkin lymphoma (cHL) combined with chemotherapy.
Note:- Brentuximab vedotin is an FDA-approved drug
Warning & Precautions
- Concomitant use of brentuximab vedotin injection with bleomycin is restricted due to pulmonary toxicity (e.g., interstitial infiltration or inflammation).
- Patients with brentuximab vedotin 50 mg should be monitored for signs and symptoms of neuropathy, such as hypoesthesia, hyperesthesia, paresthesia, discomfort, a burning sensation, weakness, or neuropathic pain.
- Complete blood counts should be assessed before each dosage of inj brentuximab vedotin 50 mg, and more frequent monitoring should be considered for patients with Grade 3 or 4 neutropenia.
- Patients with brentuximab vedotin dosage should be closely monitored while on therapy for the emergence of possible bacterial, fungal, or viral infections.
- Brentuximab vedotin can cause fetal harm if used during pregnancy. Patients should report pregnancy promptly. Patients should avoid nursing while on brentuximab 50 mg.
Documentation & Availability
What documents are required to import Brentuximab Vedotin to India?
Brentuximab Vedotin can be imported by patients or government hospitals in the patients’ name only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients id proof (issued by the government of India)
How does the order confirm?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
How to get Adcetris (Brentuximab Vedotin) in India?
Brentuximab Vedotin is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune, etc.)
- Medicine Price.
- Finding Genuine and reliable sources from Canada, Europe, the USA, and Australia
- Ensuring 100% transparency.
Brentuximab Vedotin can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after receiving a valid prescription from the Doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of Brentuximab Vedotin (prescription medicines) to any location in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for Brentuximab Vedotin price in India.
We guarantee quality and deliver this medicine anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
Indian Pharma Network can source the Brentuximab Vedotin from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
Indian Pharma Network helps to connect the patients with potential distributors, wholesalers, suppliers and dealers of Adcetris in India.
FAQ
What is the Generic Name for the trade name drug Adcetris®?
Adcetris® is the trade name of the drug Brentuximab Vedotin.
What is the dosage form of Brentuximab?
Brentuximab is available as 50 mg/vial in single use-vial.
What are the storage conditions of Brentuximab Vedotin 50 mg?
Brentuximab Vedotin 50 mg has to be stored and transported at 2-8°C (36–46°F) in its original carton to be protected from light.
One should keep this medicine out of reach of children.
Is there any generic or bio similar available for Brentuximab Vedotin 50 mg?
There is no generic or biosimilar available for Brentuximab Vedotin 50 mg globally.
What is the most common adverse effect associated with brentuximab vedotin?
The most common adverse effects of Brentuximab Vedotin are chills, nausea, dyspnea, pruritus, pyrexia, low levels of certain blood cells (neutropenia, anemia), nerve damage causing numbness or weakness in the hands and feet (peripheral neuropathy), fatigue, constipation, diarrhea, vomiting, and cough.
How much does Brentuximab vedotin cost in India?
To know the Brentuximab vedotin cost in India, you can call or WhatsApp +91-9310090915 or email info@indianpharmanetwork.in.
What are the Highlights of prescribing information for Brentuximab vedotin?
Click Here to download full Brentuximab prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.